Donga-ST announced that they made a licensing-out contract of biosimilar 'DA-3880' in Japan

Published: 2014-01-27 06:56:00

Updated: 2014-01-27 06:56:00

(Yakup Shinmoon)

On Jan 22, Donga-ST announced that they made a licensing-out contract of biosimilar 'DA-3880' that SKK (Sanwa Kagaku Kenkyusho) and Donga-ST are developing. Through the contract, SKK and bio-venture company, GTS (Gene Techno Science) will co-develop 'DA-3880' in Japan and after the completion of co-development, SKK will solely be responsible for the sales.

Through to t...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.